XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating Activities    
Net income $ 421 $ 884
Adjustments to reconcile to net cash provided by operating activities:    
Depreciation and amortization 463 459
Goodwill impairment and other asset impairment charges 539 290
Loss from equity method investment in Change Healthcare 181 0
Deferred taxes 42 (90)
Share-based compensation expense 57 79
Charges (credits) associated with last-in-first-out inventory method (3) 4
Loss (gain) from sale of businesses and equity investments (47) 113
Other non-cash items (28) 5
Changes in operating assets and liabilities, net of acquisitions:    
Receivables (812) (657)
Inventories (1,217) 162
Drafts and accounts payable 1,808 2,172
Deferred revenue (138) (254)
Taxes 86 151
Other (13) (390)
Net cash provided by operating activities 1,339 2,928
Investing Activities    
Payments for property, plant and equipment (164) (151)
Capitalized software expenditures (91) (89)
Acquisitions, net of cash and cash equivalents acquired (1,874) (2,041)
Proceeds from/ (payments for) sale of businesses and equity investments, net   (98)
Proceeds from/ (payments for) sale of businesses and equity investments, net 164  
Payments received on Healthcare Technology Net Asset Exchange 126 0
Restricted cash for acquisitions 1,469 935
Other (26) 98
Net cash used in investing activities (396) (1,346)
Financing Activities    
Proceeds from short-term borrowings 8,464 10
Repayments of short-term borrowings (8,343) (17)
Repayments of long-term debt (545) (6)
Common stock transactions:    
Issuances 83 75
Share repurchases, including shares surrendered for tax withholding (701) (58)
Dividends paid (121) (129)
Other (109) 11
Net cash used in financing activities (1,272) (114)
Effect of exchange rate changes on cash and cash equivalents 109 (52)
Net increase (decrease) in cash and cash equivalents (220) 1,416
Cash and cash equivalents at beginning of period 2,783 4,048
Cash and cash equivalents at end of period $ 2,563 $ 5,464